Meningitis Caused by the Live Varicella Vaccine Virus: Metagenomic Next Generation Sequencing, Immunology Exome Sequencing and Cytokine Multiplex Profiling
Authors:
- Prashanth S. RamachandranPRPrashanth S. Ramachandran
- Michael R. WilsonMWMichael R. Wilson
- Gaud CathoGCGaud Catho
- Geraldine Blanchard-RohnerGBGeraldine Blanchard-Rohner
- Nicoline SchiessNSNicoline Schiess
- Randall J. CohrsRandall J. Cohrs
- David BoutolleauDBDavid Boutolleau
- Sonia BurrelSonia Burrel
- Tetsushi YoshikawaTYTetsushi Yoshikawa
- Anne WapniarskiAWAnne Wapniarski
- Ethan H. HeuselEHEthan H. Heusel
- John E. CarpenterJCJohn E. Carpenter
Open Access
Abstract
Varicella vaccine meningitis is an uncommon delayed adverse event of vaccination. Varicella vaccine meningitis has been diagnosed in 12 children, of whom 3 were immunocompromised. We now report two additional cases of vaccine meningitis in twice-immunized immunocompetent children and we perform further testing on a prior third case. We used three methods to diagnose or investigate cases of varicella vaccine meningitis, none of which have been used previously on this disease. These include metagenomic next-generation sequencing and cytokine multiplex profiling of cerebrospinal fluid and immunology exome analysis of white blood cells. In one new case, the diagnosis was confirmed by metagenomic next-generation sequencing of cerebrospinal fluid. Both varicella vaccine virus and human herpesvirus 7 DNA were detected. We performed cytokine multiplex profiling on the cerebrospinal fluid of two cases and found ten elevated biomarkers: interferon gamma, interleukins IL-1RA, IL-6, IL-8, IL-10, IL-17F, chemokines CXCL-9, CXCL-10, CCL-2, and G-CSF. In a second new case, we performed immunology exome sequencing on a panel of 356 genes, but no errors were found. After a review of all 14 cases, we concluded that (i) there is no common explanation for this adverse event, but (ii) ingestion of an oral corticosteroid burst 3–4 weeks before onset of vaccine meningitis may be a risk factor in some cases.Keywords
Funding Information
- American Academy of Neurology (P0534134)
- National Institute of Neurological Disorders and Stroke (NS096117)
- National Institute of Allergy and Infectious Diseases (AI153817)
This publication has 58 references indexed in Scilit:
- The Attenuated Genotype of Varicella-Zoster Virus Includes an ORF0 Transitional Stop Codon MutationJournal of Virology, 2012
- Pangaea and the Out-of-Africa Model of Varicella-Zoster Virus Evolution and PhylogeographyJournal of Virology, 2012
- Novel Genetic Variation Identified at Fixed Loci in ORF62 of the Oka Varicella Vaccine and in a Case of Vaccine-Associated Herpes ZosterJournal of Clinical Microbiology, 2012
- Varicella Zoster Disease of the Central Nervous System: Epidemiological, Clinical, and Laboratory Features 10 Years after the Introduction of the Varicella VaccineThe Journal of Infectious Diseases, 2011
- Upregulation of CXCL10 in Human Dorsal Root Ganglia during Experimental and Natural Varicella-Zoster Virus InfectionJournal of Virology, 2011
- Prognostic value of cerebrospinal fluid cytokine changes in herpes simplex virus encephalitisCytokine, 2009
- Varicella Vaccine in the United States: A Decade of Prevention and the Way ForwardThe Journal of Infectious Diseases, 2008
- Effectiveness of live varicella vaccineExpert Opinion on Biological Therapy, 2004
- Seroepidemiology of human herpesvirus 7 in healthy children and adults in JapanJournal of Medical Virology, 1993
- Reactivation of Varicella Virus by Cortisone TherapyBMJ, 1953